RVO
HomeMarketplace

ServiceUpdated on 13 August 2025

Viral Vector Development & Manufacturing

Sophia Kolbe

Business Developer at NecstGen

Leiden, Netherlands

About

There is no one-size-fits-all solution for viral vector manufacturing. Just like the therapy you are developing, you require a tailored approach. NecstGen offers a wide range of services and expert professionals to support you with that.

Development:

  • Translational activities to create GMP compliant manufacturing 

  • Process design and optimisation 

  • Scale-up to clinically relevant volumes

  • Automation and closed processes

Manufacturing:

  • Pre-clinical or toxicology study material 

  • Phase I to Phase III clinical trial material

Viral Vector:

  • Lentiviruses (LV)

  • Adeno-associated viruses (AAV)

  • Oncolytic viruses 

  • Exosomes and Extracellular Vesicles (EVs)

  • Others

 We will be happy to discuss and help you bring your cell therapies to patients.

Type

  • Development
  • Manufacturing

Applies to

  • Innovative therapies - Gene therapy
  • Innovative therapies - Oncolytic viruses

Similar opportunities